Skip to main content
. Author manuscript; available in PMC: 2022 Mar 4.
Published in final edited form as: Expert Rev Vaccines. 2021 Mar 4;20(2):97–112. doi: 10.1080/14760584.2021.1880898

Table 1:

(b) Potential Plasmodium vivax vaccine candidates targeting different stages of the life cycle.

Different stages of life cycle Potential P. vivax vaccine candidates
Merozoite graphic file with name nihms-1667293-t0001.jpg PvDBP [1,2,79]
PvRBPs [10,11]
PvEBP2 [12]
PvMSP1[1318]
PvAMA1[14]
Sporozoite graphic file with name nihms-1667293-t0002.jpg PvCSP [4,5,1935]
PvTRAP [22,3537]
PvCelTOS [34,35,3840]
Macrogametocyte

Microgametocyte
graphic file with name nihms-1667293-t0003.jpg Pvs25 [6,41,42]
Pvs28 [42]
Pvs230 [43,44]
Oökinete graphic file with name nihms-1667293-t0004.jpg

PvDBP- P. vivax Duffy Binding protein region

PvRBPs- P. vivax Reticulocyte binding proteins

PvEBP2- P. vivax Erythrocyte binding protein2

PvMSP1- P. vivax Merozoite surface protein 1

PvAMA1- P. vivax Apical membrane antigen 1

PvCSP- P. vivax Circumsporozoite protein

PvTRAP- P. vivax Thrombospondin-related anonymous protein

PvCelTOS- P. vivax Cell-traversal protein for oökinetes and sporozoites

Pvs- P. vivax sexual stage